New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...
The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...
Researchers at UW’s School of Medicine and the Institute for Research in Biomedicine Barcelona may have found an additional ...
Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...
Across conversations on precision oncology, malignant hematology, cellular therapies, and social determinants of health (SDOH ...
Move positions company at the heart of Cambridge's innovation ecosystem to accelerate growth and collaboration in infection prevention.
"Fueled by advances in NGS and precision medicine, China’s DNA sequencing market sees rapid growth amid strong government support, rising clinical applications, and innovation hubs in Guangdong, ...
Visit NGD at Booth #712 to learn more about the NGD system, which automates both sample preparation and bioinformatics, as well as generates actionable reports for Infection Prevention teams.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback